235 related articles for article (PubMed ID: 18634439)
1. [Estramustine phosphate withdrawal syndrome in relapsed prostate cancer: two case reports].
Kobayashi S; Tsukamoto T; Tohsaka A; Tohma T
Hinyokika Kiyo; 2008 Jun; 54(6):423-6. PubMed ID: 18634439
[TBL] [Abstract][Full Text] [Related]
2. Dramatic decline in prostate-specific antigen by withdrawal of estramustine phosphate in hormone refractory prostate cancer.
Kobayashi M; Kuramoto H; Ota J; Fujimoto N
Int J Urol; 2006 Jul; 13(7):1019-21. PubMed ID: 16882080
[TBL] [Abstract][Full Text] [Related]
3. Final report on low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer.
Kitamura T; Suzuki M; Nishimatsu H; Kurosaki T; Enomoto Y; Fukuhara H; Kume H; Takeuchi T; Miao L; Jiangang H; Xiaoqiang L
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S34-40. PubMed ID: 20094950
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of estramustine phosphate for hormone refractory prostate cancer patients following androgen deprivation therapy.
Hirano D; Minei S; Kishimoto Y; Yamaguchi K; Hachiya T; Yoshida T; Yoshikawa T; Endoh M; Yamanaka Y; Yamamoto T; Satoh Y; Ishida H; Okada K; Takimoto Y
Urol Int; 2005; 75(1):43-9. PubMed ID: 16037707
[TBL] [Abstract][Full Text] [Related]
5. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
[TBL] [Abstract][Full Text] [Related]
6. [Small cell carcinoma of the prostate: a case report].
Sakai H; Tsuruta T; Wajiki M
Hinyokika Kiyo; 2004 Apr; 50(4):269-71. PubMed ID: 15188622
[TBL] [Abstract][Full Text] [Related]
7. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report].
Segawa N; Inamoto T; Ibuki N; Mizutani Y; Azuma H; Tsuji M; Katsuoka Y
Hinyokika Kiyo; 2010 Jan; 56(1):49-54. PubMed ID: 20104011
[TBL] [Abstract][Full Text] [Related]
8. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
Suzuki M; Mamun MR; Hara K; Ozeki T; Yamada Y; Kadowaki T; Honda H; Yanagihara Y; Ito YM; Kameyama S; Ohta N; Hosoi T; Arai T; Sawabe M; Takeuchi T; Takahashi S; Kitamura T
Eur Urol; 2005 Nov; 48(5):752-9. PubMed ID: 16126332
[TBL] [Abstract][Full Text] [Related]
9. Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: a case report.
Kinebuchi Y; Noguchi W; Irie K; Nakayama T; Kato H; Nishizawa O
Int J Urol; 2007 Feb; 14(2):147-9. PubMed ID: 17302572
[TBL] [Abstract][Full Text] [Related]
10. EMP combination chemotherapy and low-dose monotherapy in advanced prostate cancer.
Kitamura T; Nishimatsu H; Hamamoto T; Tomita K; Takeuchi T; Ohta N
Expert Rev Anticancer Ther; 2002 Feb; 2(1):59-71. PubMed ID: 12113067
[TBL] [Abstract][Full Text] [Related]
11. [Antiandrogen withdrawal syndrome in the hormonal treatment of metastatic prostatic cancer in hormonal escape].
Barthélémy Y; Colombel M; Gasman D; Patard JJ; Chopin D; Abbou CC
Prog Urol; 1996 Feb; 6(1):93-7. PubMed ID: 8624534
[TBL] [Abstract][Full Text] [Related]
12. [Prostatic cancer in a young adult: a report of 2 cases].
Sasaki H; Miki J; Hasegawa T; Hasegawa N; Ikemoto I; Ohishi Y
Hinyokika Kiyo; 2004 Jan; 50(1):57-9. PubMed ID: 15032019
[TBL] [Abstract][Full Text] [Related]
13. [Multiple myeloma diagnosed during hormonal therapy for prostate cancer: report of two cases].
Yoshinaga A; Okada Y; Ichiyanagi N; Kamata S
Hinyokika Kiyo; 2012 May; 58(5):243-7. PubMed ID: 22767278
[TBL] [Abstract][Full Text] [Related]
14. Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade.
Soga N; Arima K; Sugimura Y
Jpn J Clin Oncol; 2008 Sep; 38(9):617-22. PubMed ID: 18697759
[TBL] [Abstract][Full Text] [Related]
15. [Marked effectiveness of the LH-RH analogue in a case of prostate cancer with large lymph node metastasis].
Takezawa Y; Ohtake N; Nakano K; Uchida T; Okamura K; Yamanaka H
Hinyokika Kiyo; 1994 Aug; 40(8):721-4. PubMed ID: 7942372
[TBL] [Abstract][Full Text] [Related]
16. [A case of prostate cancer with cyst formation].
Ishida K; Kubota Y; Takada T; Yamada T; Nakano M; Takahashi Y; Ishihara S; Deguchi T
Hinyokika Kiyo; 2003 Apr; 49(4):235-7. PubMed ID: 12784721
[TBL] [Abstract][Full Text] [Related]
17. Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.
Numata K; Miura N; Azuma K; Karashima T; Kasahara K; Nakatsuzi H; Hashine K; Sumiyoshi Y
Hinyokika Kiyo; 2007 Feb; 53(2):99-104. PubMed ID: 17352158
[TBL] [Abstract][Full Text] [Related]
18. [A case of huge prostate cancer].
Miyajima A; Ikeuchi K
Hinyokika Kiyo; 1995 Sep; 41(9):683-5. PubMed ID: 7484533
[TBL] [Abstract][Full Text] [Related]
19. [A case of primary transitional cell carcinoma of the prostate].
Morikawa H; Cho M; Takada S; Fujimoto K; Uemura H; Ozono S; Hirao Y; Natsume O
Hinyokika Kiyo; 2003 Jun; 49(6):357-60. PubMed ID: 12894737
[TBL] [Abstract][Full Text] [Related]
20. [Prostate cancer detected from pleural effusion: two case reports].
Masue T; Hattori S; Takagi K; Uno M; Komeda H; Fujimoto Y
Hinyokika Kiyo; 2008 Aug; 54(8):565-8. PubMed ID: 18788449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]